CAS ID: | 14605-22-2 |
Molecular Formula: | C26H45NO5S |
Molecular Weight: | 483.7 g/mol |
Monoisotopic Mass: | 483.3018 g/mol |
Class: | Small Molecule |
Natural Product: | No |
Other Names: | Taurolithocholate | Tauroursodeoxycholic acid |
Analysis: | Drug repositioning mechanism analysis |
InChI: | InChI=1S/C26H45NO5S/c1-17(4-9-24(29)27-14-15-33(30,31)32)21-7-8-22-20-6-5-18-16-19(28)10-12-25(18,2)23(20)11-13-26(21,22)3/h17-23,28H,4-16H2,1-3H3,(H,27,29)(H,30,31,32)/t17-,18-,19-,20+,21-,22+,23+,25+,26-/m1/s1 | See All |
InChI Key: | QBYUNVOYXHFVKC-GBURMNQMSA-N | |
Smiles: | C[C@H](CCC(=O)NCCS(=O)(=O)O)[C@H]1CC[C@H]2[C@@H]3CC[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@]12C | See All |
Molfile: | Download |
Reference Record 1
PubMed ID | 28883502 | Target ID | |
Uniprot ID | Name | ||
Model | human,mice | Fibrosis Disease | Ovarian fibrosis |
Process I | |||
Process II | |||
Process III | prevenet collagen deposition | ||
Mechanism |
Reference Record 2
PubMed ID | 21274875 | Target ID | |
Uniprot ID | Name | ||
Model | vitro,rat | Fibrosis Disease | Liver fibrosis |
Process I | attenue inflammation | ||
Process II | cells proliferation | ||
Process III | prevenet collagen deposition | ||
Mechanism |
Reference Record 3
PubMed ID | 21410058 | Target ID | |
Uniprot ID | Name | ||
Model | rat | Fibrosis Disease | Liver fibrosis |
Process I | |||
Process II | |||
Process III | prevenet collagen deposition | ||
Mechanism |
Trial Record 1
ClinicalTrial ID | NCT02937012 | Disease | Liver fibrosis |
Phase | Phase 3 | Status | Recruiting |
First Received | October 18, 2016 | Last Verified | April 23, 2018 |
Sponsor | Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran |
Trial Record 2
ClinicalTrial ID | NCT01857284 | Disease | Liver fibrosis |
Phase | Phase 3 | Status | Completed |
First Received | May 20, 2013 | Last Verified | May 20, 2013 |
Sponsor | Beijing Friendship Hospital |
PubChem: | 439763 |
ChEMBL: | CHEMBL408701 |